Advertisement

Comparison of expression profiling of circular RNAs in vitreous humour between diabetic retinopathy and non-diabetes mellitus patients

  • Miao He
  • Wei Wang
  • Honghua Yu
  • Decai Wang
  • Dan Cao
  • Yunkao Zeng
  • Qiaowei Wu
  • Pingting Zhong
  • Zhixing Cheng
  • Yunyan Hu
  • Liang ZhangEmail author
Original Article
  • 62 Downloads
Part of the following topical collections:
  1. Eye Complications of Diabetes

Abstract

Aims

To compare circular (circRNA) expression levels in the vitreous humour between PDR (proliferative diabetic retinopathy) and the control groups.

Methods

The present study collected vitreous humour samples of both the PDR group and the control group (composed of rhegmatogenous retinal detachment, idiopathic macular hole and idiopathic macular epiretinal membrane). All the samples were subjected to circRNA and mRNA sequencing as well as bioinformatic analysis.

Results

The vitreous humour of the PDR and control groups was collected during PPV surgery. Compared to the control group, 122 upregulated and 9 downregulated circRNAs, and 818 upregulated mRNAs and 864 downregulated mRNAs were identified. We further selected 12 circRNAs to validate the RNA expression level by qPCR; results showed that with the exception of 2 downregulated circRNAs the remaining were significantly upregulated in the PDR group, which was consistent with RNA sequencing results. Bioinformatic analysis was conducted to predict possible miRNAs absorbed by circRNAs. Each circRNA could interact with at least five miRNAs. We randomly chose three miRNAs to test the expression level in the vitreous humour by qPCR and found these miRNAs were significantly downregulated in the PDR group.

Conclusions

The changed profiling of circRNAs in the vitreous humour was reliable and may become a promising biomarker of DR and the circRNA–miRNA–mRNA network. It may also play an important role in the progression of DR.

Keywords

Diabetic retinopathy circRNA miRNA mRNA Vitreous humour 

Notes

Authors’ contribution

All authors contributed to the study conception and design. Material preparation, data collection and analysis were performed by Miao He, Wei Wang and Liang Zhang. The first draft of the manuscript was written by Miao He, and all authors commented on previous versions of the manuscript. All authors read and approved the final manuscript.

Funding

This study was supported by the National Natural Science Foundation of China (ID 81900866) and Medical Scientific Research Foundation of Guangdong Province (Grant Number B2018096).

Compliance with Ethical Standards

Conflict of interest

The authors declare that they have no conflict of interest.

Ethical Standard Statement

All procedures performed in studies involving human participants were in accordance with the ethical standards of the institutional and/or national research committee and with the 1964 Helsinki Declaration and its later amendments or comparable ethical standards. The current study was approved by the Ethical Review Committee of Guangdong Provincial People’s Hospital (Number 2016232A).

Informed consent

Informed consent was obtained from all patients for being included in the study.

References

  1. 1.
    Leasher JL, Bourne RR, Flaxman SR et al (2016) Global estimates on the number of people blind or visually impaired by diabetic retinopathy: a meta-analysis from 1990 to 2010. Diabetes Care 39:1643–1649CrossRefGoogle Scholar
  2. 2.
    Memczak S, Jens M, Elefsinioti A et al (2013) Circular RNAs are a large class of animal RNAs with regulatory potency. Nature 495:333–338CrossRefGoogle Scholar
  3. 3.
    Li X, Yang L, Chen LL (2018) The biogenesis, functions, and challenges of circular RNAs. Mol Cell 71:428–442CrossRefGoogle Scholar
  4. 4.
    Vo JN, Cieslik M, Zhang Y et al (2019) The landscape of circular RNA in cancer. Cell 176:869–881CrossRefGoogle Scholar
  5. 5.
    Jae N, Heumuller AW, Fouani Y, Dimmeler S (2019) Long non-coding RNAs in vascular biology and disease. Vasc Pharmacol 114:13–22CrossRefGoogle Scholar
  6. 6.
    Xu H, Guo S, Li W, Yu P (2015) The circular RNA Cdr1as, via miR-7 and its targets, regulates insulin transcription and secretion in islet cells. Sci Rep 5:12453CrossRefGoogle Scholar
  7. 7.
    Shan K, Liu C, Liu BH et al (2017) Circular noncoding RNA HIPK3 mediates retinal vascular dysfunction in diabetes mellitus. Circulation 136:1629–1642CrossRefGoogle Scholar
  8. 8.
    Zhao Z, Li X, Jian D, Hao P, Rao L, Li M (2017) Hsa_circ_0054633 in peripheral blood can be used as a diagnostic biomarker of pre-diabetes and type 2 diabetes mellitus. Acta Diabetol 54:237–245CrossRefGoogle Scholar
  9. 9.
    Liu C, Yao MD, Li CP et al (2017) Silencing of circular RNA-ZNF609 ameliorates vascular endothelial dysfunction. Theranostics 7:2863–2877CrossRefGoogle Scholar
  10. 10.
    Zhang SJ, Chen X, Li CP et al (2017) Identification and characterization of circular RNAs as a new class of putative biomarkers in diabetes retinopathy. Investig Ophthalmol Vis Sci 58:6500–6509CrossRefGoogle Scholar
  11. 11.
    Gu Y, Ke G, Wang L, Zhou E, Zhu K, Wei Y (2017) Altered expression profile of circular RNAs in the serum of patients with diabetic retinopathy revealed by microarray. Ophthalmic Res 58:176–184CrossRefGoogle Scholar
  12. 12.
    Yao J, Hu LL, Li XM et al (2019) Comprehensive circular RNA profiling of proliferative vitreoretinopathy and its clinical significance. Biomed Pharmacother 111:548–554CrossRefGoogle Scholar
  13. 13.
    Nawaz IM, Rezzola S, Cancarini A et al (2019) Human vitreous in proliferative diabetic retinopathy: characterization and translational implications. Prog Retin Eye Res 72:100756CrossRefGoogle Scholar
  14. 14.
    Salzman J (2016) Circular RNA expression: its potential regulation and function. Trends Genet 32:309–316CrossRefGoogle Scholar
  15. 15.
    Yang L, Peng X, Li Y et al (2019) Long non-coding RNA HOTAIR promotes exosome secretion by regulating RAB35 and SNAP23 in hepatocellular carcinoma. Mol Cancer 18:78CrossRefGoogle Scholar
  16. 16.
    Zhu Z, Yang Q, Zhang B, Wu W, Yuan F, Zhu Z (2019) MiR-106b promotes metastasis of early gastric cancer by targeting ALEX1 in vitro and in vivo. Cell Physiol Biochem 52:606–616CrossRefGoogle Scholar
  17. 17.
    Sun B, Ding Y, Jin X, Xu S, Zhang H (2019) Long non-coding RNA h19 promotes corneal neovascularization by targeting MicroRNA-29c. Biosci Rep.  https://doi.org/10.1042/BSR20182394 CrossRefPubMedPubMedCentralGoogle Scholar
  18. 18.
    Yan B, Yao J, Liu JY et al (2015) LncRNA-MIAT regulates microvascular dysfunction by functioning as a competing endogenous RNA. Circ Res 116:1143–1156CrossRefGoogle Scholar
  19. 19.
    Biswas S, Thomas AA, Chen S et al (2018) MALAT1: an epigenetic regulator of inflammation in diabetic retinopathy. Sci Rep 8:6526CrossRefGoogle Scholar
  20. 20.
    Raut SK, Khullar M (2018) The big entity of new RNA world: long non-coding RNAs in microvascular complications of diabetes. Front Endocrinol (Lausanne) 9:300CrossRefGoogle Scholar
  21. 21.
    Qiu GZ, Tian W, Fu HT, Li CP, Liu B (2016) Long noncoding RNA-MEG3 is involved in diabetes mellitus-related microvascular dysfunction. Biochem Biophys Res Commun 471:135–141CrossRefGoogle Scholar
  22. 22.
    Shan K, Li CP, Liu C, Liu X, Yan B (2017) RNCR22: a regulator of diabetes mellitus-related retinal microvascular dysfunction. Biochem Biophys Res Commun 482:777–783CrossRefGoogle Scholar
  23. 23.
    Li CP, Wang SH, Wang WQ, Song SG, Liu XM (2017) Long noncoding RNA-Sox2OT knockdown alleviates diabetes mellitus-induced retinal ganglion cell (RGC) injury. Cell Mol Neurobiol 37:361–369CrossRefGoogle Scholar
  24. 24.
    Li XJ (2018) Long non-coding RNA nuclear paraspeckle assembly transcript 1 inhibits the apoptosis of retina Muller cells after diabetic retinopathy through regulating miR-497/brain-derived neurotrophic factor axis. Diabetes Vasc Dis Res 15:204–213CrossRefGoogle Scholar
  25. 25.
    Dong N, Xu B, Shi H (2018) Long noncoding RNA MALAT1 acts as a competing endogenous RNA to regulate Amadori-glycated albumin-induced MCP-1 expression in retinal microglia by a microRNA-124-dependent mechanism. Inflamm Res 67:913–925CrossRefGoogle Scholar
  26. 26.
    Tong P, Peng QH, Gu LM, Xie WW, Li WJ (2018) LncRNA-MEG3 alleviates high glucose induced inflammation and apoptosis of retina epithelial cells via regulating miR-34a/SIRT1 axis. Exp Mol Pathol 107:102–109CrossRefGoogle Scholar
  27. 27.
    Kos A, Dijkema R, Arnberg AC, van der Meide PH, Schellekens H (1986) The hepatitis delta (delta) virus possesses a circular RNA. Nature 323:558–560CrossRefGoogle Scholar
  28. 28.
    Huang C, Zhu HJ, Li H et al (2018) P38-MAPK pathway is activated in retinopathy of microvascular disease of STZ-induced diabetic rat model. Eur Rev Med Pharmacol Sci 22:5789–5796PubMedGoogle Scholar
  29. 29.
    Wang Z, Liu CH, Huang S, Chen J (2019) Wnt signaling in vascular eye diseases. Prog Retin Eye Res 70:110–133CrossRefGoogle Scholar
  30. 30.
    Jin J, Yuan F, Shen MQ, Feng YF, He QL (2013) Vascular endothelial growth factor regulates primate choroid-retinal endothelial cell proliferation and tube formation through PI3 K/Akt and MEK/ERK dependent signaling. Mol Cell Biochem 381:267–272CrossRefGoogle Scholar
  31. 31.
    Merimee TJ, Zapf J, Froesch ER (1983) Insulin-like growth factors. Studies in diabetics with and without retinopathy. N Engl J Med 309:527–530CrossRefGoogle Scholar
  32. 32.
    Cheung N, Mitchell P, Wong TY (2010) Diabetic retinopathy. Lancet 376:124–136CrossRefGoogle Scholar
  33. 33.
    Haurigot V, Villacampa P, Ribera A et al (2009) Increased intraocular insulin-like growth factor-I triggers blood-retinal barrier breakdown. J Biol Chem 284:22961–22969CrossRefGoogle Scholar
  34. 34.
    Tonade D, Liu H, Palczewski K, Kern TS (2017) Photoreceptor cells produce inflammatory products that contribute to retinal vascular permeability in a mouse model of diabetes. Diabetologia 60:2111–2120CrossRefGoogle Scholar

Copyright information

© Springer-Verlag Italia S.r.l., part of Springer Nature 2019

Authors and Affiliations

  1. 1.Department of Ophthalmology, Guangdong Academy of Medical SciencesGuangdong Provincial People’s HospitalGuangzhouChina
  2. 2.Shantou University Medical CollegeShantouChina
  3. 3.Southern Medical UniversityGuangzhouChina
  4. 4.Zhongshan Ophthalmic Center, State Key Laboratory of OphthalmologySun Yat-Sen UniversityGuangzhouChina

Personalised recommendations